Brief: Inspira Technologies Signs Agreement To Conduct Clinical Study Of Blood Sensor
Dec 14 (Reuters) - Inspira Technologies Oxy BHN Ltd
IINN.O :
* INSPIRA TECHNOLOGIES OXY BHN LTD - SIGNS AGREEMENT TO
CONDUCT
CLINICAL STUDY OF HYLATM BLOOD SENSOR
* INSPIRA TECHNOLOGIES OXY BHN LTD - SIGNED AGREEMENT TO
CONDUCT
STUDY WITH SHEBA MEDICAL CENTER IN ISRAEL, STUDY EXPECTED TO
COMMENCE IN THE Q1 2023
Source text: (https://bit.ly/3HASS9H)
Further company coverage: IINN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Qtrex Quantum
See all newsBrief: Qtrex Announces Receipt Of Nasdaq Notification Regarding Minimum Bid Price Requirement
Brief: Qtrex Quantum Ltd In Discussions With A US Department Of Defense’S Research Laboratory To Establish A Joint Quantum Development Program
Brief: Qtrex Quantum - Offers Up To 6.8 Million Ordinary Shares For Resale By Selling Shareholder - SEC Filing
Brief: Qtrex Expands Into Quantum Processor Interface With Single-Build Cryogenic Chip Carrier
NASDAQ RESUMED AT 11:03 AM